The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...

Illumina has been barred from exporting its DNA sequencers to China, which closed | Illumina has been barred from exporting ...

GlobalData’s senior medical analyst says the ban will add to a downward trend for Illumina in the Chinese market.

Brown Advisors, an investment management company, released its “Brown Advisors Global Leaders Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. In the letter ...

Illumina is not banned from operating in the country and will continue to serve its existing customers, a company ...

The solutions – spanning genomics, spatial transcriptomics, single cell analysis ... today at the Advances in Genome Biology and Technology (AGBT) General Meeting. Illumina announced today ...

Illumina unveils first-of-its-kind spatial transcriptomics technology: San Diego Friday, February 21, 2025, 17:00 Hrs [IST] Illumina, Inc. announced a new spatial technology progr ...

Illumina, Inc. ILMN recently entered into a collaboration with Broad Clinical Labs to rapidly streamline and scale single-cell projects with cutting-edge tools and workflows. Together, the companies ...

Since purchasing Solexa with its Genome Reader instrument in 2007, Illumina’s continued innovation ... thinking of our people and exacting analysis of our research processes.

Currently in early access, Illumina's 5-base solution for methylation analysis enables simultaneous genetic variant and methylation detection in a single assay. DNA methylation impacts how and ...